Q3 2024 Earnings Call Transcript November 6, 2024 Coherus BioSciences, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.1. Operator: Good day, and thank you for standing ...

More doctors are looking out for the condition. But that’s not enough to explain the increase in the nation’s overall ...

*BY REGISTERING AN ACCOUNT, YOU ARE AGREEING TO HAVE YOUR EMAIL ADDRESS ADDED TO THE LOWCOUNTRY PARENT LATELY NEWSLETTER AND ...

It’s common to experience a range of emotions when your husband, wife, or partner is diagnosed with cancer. You may feel like ...

A third of former NFL players believe they have a chronic brain condition linked to football. A new blood test could help tackle the issue.

In this special Veterans Day conversation, Anne Mork, R.N., vice president/chief nursing officer of ambulatory and nursing support services at UW Health, and Luke Sticht, former vice president and ...

"The challenge was to develop a technology that is actually applicable in clinical practice," Van Mulken ... In breast reconstruction after cancer, for example, not only the shape of the breast ...

Clinical test volume for the third quarter grew 21% year-over ... As I mentioned earlier, we had another record quarter of reported biopharma samples growing 40% year-over-year. Biopharma revenue grew ...

Generated $196.8 million in 3Q 2024 revenues, including $176.6 million in U.S. net product salesGrew SYFOVRE® (pegcetacoplan injection) demand by ...

A custom-designed program that’s thought to be the first-of-its-kind in the nation to pique the interest of high school ...

Donald Trump and Kamala Harris have presented sharply different proposals for alleviating pressure on families. But not all forms of stress are created equal.